Axogen Inc vs SpaceX — how do they compare? Axogen Inc trades at $38.47 (market cap $2.06B), while SpaceX trades at $137.95 (market cap $1.79T). The key difference: SpaceX is far larger — about 868.9× Axogen Inc's market cap, and Axogen Inc is trading nearer its 52-week high, SpaceX nearer its low. Which is the better fit depends on your goals.
| AXGN | SPCX | |
|---|---|---|
Market Cap | $2.06B | $1.79T |
Sector | Technology | Technology |
52-Week High | $46.19 | $202.09 |
52-Week Low | $11.28 | $135.00 |
Enterprise Value | $1.98B | $1.81T |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
SpaceX (SPCX) trades at $139.14, down 4.33% with bearish technical signals despite analyst optimism. The stock shows weak fundamentals with negative profitability (-45% net margin) and extreme valuations (P/S 92.17, EV/EBITDA 957.25). Recent Q1 2026 earnings missed expectations, though inclusion in the Nasdaq-100 provides institutional support. Cash flow remains positive primarily from financing activities.
Long-term growth potential in space economy contrasts with current overvaluation and execution risks. Analyst consensus remains bullish with $239.23 price target, but investors face volatility from high valuations and geopolitical tensions. The stock presents high-risk speculation on future space dominance rather than current fundamentals.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →